Prudential plc’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $460K | Hold |
2,508
| – | – | ﹤0.01% | 591 |
|
|
2025
Q4 | $441K | Hold |
2,508
| – | – | ﹤0.01% | 607 |
|
|
2025
Q3 | $351K | Hold |
2,508
| – | – | ﹤0.01% | 659 |
|
|
2025
Q2 | $315K | Hold |
2,508
| – | – | ﹤0.01% | 712 |
|
|
2025
Q1 | $343K | Hold |
2,508
| – | – | ﹤0.01% | 664 |
|
|
2024
Q4 | $384K | Hold |
2,508
| – | – | ﹤0.01% | 667 |
|
|
2024
Q3 | $486K | Hold |
2,508
| – | – | ﹤0.01% | 648 |
|
|
2024
Q2 | $581K | Sell |
2,508
-10,444
| -81% | -$2.27M | ﹤0.01% | 577 |
|
|
2024
Q1 | $2.79M | Buy |
12,952
+5,910
| +84% | +$1.38M | 0.02% | 350 |
|
|
2023
Q4 | $1.82M | Sell |
7,042
-7,741
| -52% | -$1.9M | 0.02% | 435 |
|
|
2023
Q3 | $3.8M | Sell |
14,783
-132
| -0.9% | -$35.3K | 0.04% | 259 |
|
|
2023
Q2 | $4.25M | Buy |
14,915
+6,776
| +83% | +$2.02M | 0.05% | 238 |
|
|
2023
Q1 | $2.26M | Buy |
8,139
+22
| +0.3% | +$6.09K | 0.03% | 347 |
|
|
2022
Q4 | $2.25M | Buy |
8,117
+4,453
| +122% | +$1.26M | 0.03% | 345 |
|
|
2022
Q3 | $978K | Buy |
3,664
+409
| +13% | +$86.9K | 0.02% | 406 |
|
|
2022
Q2 | $664K | Sell |
3,255
-112
| -3% | -$22.9K | 0.01% | 482 |
|
|
2022
Q1 | $709K | Sell |
3,367
-369
| -10% | -$80.2K | 0.01% | 500 |
|
|
2021
Q4 | $896K | Buy |
+3,736
| New | +$961K | 0.01% | 386 |
|
|
2021
Q1 | – | Sell |
-12,963
| Closed | -$3.17M | – | 595 |
|
|
2020
Q4 | $3.17M | Sell |
12,963
-612
| -5% | -$158K | 0.02% | 330 |
|
|
2020
Q3 | $3.85M | Buy |
+13,575
| New | +$3.79M | 0.02% | 300 |
|
|
2019
Q4 | – | Sell |
-178,663
| Closed | -$41.6M | – | 585 |
|
|
2019
Q3 | $41.6M | Buy |
178,663
+10,572
| +6% | +$2.46M | 0.12% | 171 |
|
|
2019
Q2 | $39.3M | Buy |
168,091
+24,640
| +17% | +$5.69M | 0.12% | 172 |
|
|
2019
Q1 | $33.9M | Buy |
143,451
+23,478
| +20% | +$7.39M | 0.12% | 157 |
|
|
2018
Q4 | $36.1M | Sell |
119,973
-887
| -0.7% | -$283K | 0.15% | 149 |
|
|
2018
Q3 | $42.7M | Sell |
120,860
-924
| -0.8% | -$318K | 0.14% | 152 |
|
|
2018
Q2 | $35.3M | Buy |
121,784
+3,416
| +3% | +$960K | 0.11% | 183 |
|
|
2018
Q1 | $32.4M | Sell |
118,368
-9,824
| -8% | -$3.05M | 0.1% | 193 |
|
|
2017
Q4 | $40.8M | Buy |
128,192
+8,700
| +7% | +$2.79M | 0.12% | 176 |
|
|
2017
Q3 | $37.4M | Buy |
119,492
+7,749
| +7% | +$2.29M | 0.12% | 186 |
|
|
2017
Q2 | $30.3M | Buy |
111,743
+42,258
| +61% | +$11.2M | 0.1% | 205 |
|
|
2017
Q1 | $19M | Buy |
69,485
+10,911
| +19% | +$3.09M | 0.06% | 244 |
|
|
2016
Q4 | $15.3M | Buy |
58,574
+36,005
| +160% | +$10.7M | 0.05% | 260 |
|
|
2016
Q3 | $7.07M | Sell |
22,569
-4,278
| -16% | -$1.27M | 0.03% | 308 |
|
|
2016
Q2 | $6.49M | Sell |
26,847
-1,400
| -5% | -$369K | 0.03% | 307 |
|
|
2016
Q1 | $7.35M | Buy |
28,247
+22,562
| +397% | +$5.96M | 0.03% | 298 |
|
|
2015
Q4 | $1.74M | Buy |
5,685
+4,196
| +282% | +$1.21M | 0.01% | 398 |
|
|
2015
Q3 | $435K | Sell |
1,489
-84
| -5% | -$27.7K | ﹤0.01% | 445 |
|
|
2015
Q2 | $635K | Buy |
1,573
+84
| +6% | +$33.7K | ﹤0.01% | 428 |
|
|
2015
Q1 | $629K | Hold |
1,489
| – | – | ﹤0.01% | 440 |
|
|
2014
Q4 | $505K | Hold |
1,489
| – | – | ﹤0.01% | 423 |
|
|
2014
Q3 | $493K | Hold |
1,489
| – | – | ﹤0.01% | 431 |
|
|
2014
Q2 | $470K | Hold |
1,489
| – | – | ﹤0.01% | 421 |
|
|
2014
Q1 | $455K | Hold |
1,489
| – | – | ﹤0.01% | 419 |
|
|
2013
Q4 | $417K | Hold |
1,489
| – | – | ﹤0.01% | 423 |
|
|
2013
Q3 | $358K | Sell |
1,489
-100
| -6% | -$22.4K | ﹤0.01% | 423 |
|
|
2013
Q2 | $342K | Buy |
+1,589
| New | +$340K | ﹤0.01% | 385 |
|
Other funds holding BIIB
VCM
VPM
Prudential plc's BIIB Position: Q1 2026 in Review
Prudential plc held its Biogen (BIIB) position steady in Q1 2026 at 2,508 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #591.
Prudential plc first reported a position in BIIB in Q2 2013 and has held it in 46 quarters since. The position peaked at $42.7M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Prudential plc held 2,508 shares of Biogen worth $460K as of Q1 2026.
- Prudential plc left its Biogen share count unchanged in Q1 2026.
- Biogen made up ﹤0.01% of Prudential plc's portfolio in Q1 2026, its #591 holding.
- Prudential plc first reported a position in Biogen in Q2 2013 and has held it in 46 quarters since.
- Prudential plc's Biogen position peaked at $42.7M in Q3 2018.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.